Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study

This phase II, randomised, double-blind, multicentre study (NCT00930982) investigated the safety and efficacy of ciprofloxacin dry powder for inhalation (DPI) in patients with non-cystic fibrosis bronchiectasis. Adults who were culture positive for pre-defined potential respiratory pathogens (includ...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Wilson, Robert, Welte, Tobias, Polverino, Eva, De Soyza, Anthony, Greville, Hugh, O'Donnell, Anne, Alder, Jeff, Reimnitz, Peter, Hampel, Barbara
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: European Respiratory Society 2013
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3640146/
https://ncbi.nlm.nih.gov/pubmed/23018904
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/09031936.00071312
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller